New England Capital Financial Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-200
Closed -$176K 413
2023
Q4
$176K Hold
200
0.11% 55
2023
Q3
$165K Hold
200
0.11% 56
2023
Q2
$144K Hold
200
0.09% 59
2023
Q1
$164K Hold
200
0.12% 58
2022
Q4
$144K Buy
+200
New +$144K 0.1% 59